Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1515247rdf:typepubmed:Citationlld:pubmed
pubmed-article:1515247lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:1515247lifeskim:mentionsumls-concept:C0042963lld:lifeskim
pubmed-article:1515247lifeskim:mentionsumls-concept:C0003297lld:lifeskim
pubmed-article:1515247lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:1515247lifeskim:mentionsumls-concept:C2587213lld:lifeskim
pubmed-article:1515247lifeskim:mentionsumls-concept:C0040808lld:lifeskim
pubmed-article:1515247lifeskim:mentionsumls-concept:C0205421lld:lifeskim
pubmed-article:1515247pubmed:issue8-9lld:pubmed
pubmed-article:1515247pubmed:dateCreated1992-10-8lld:pubmed
pubmed-article:1515247pubmed:abstractTextAntiemetic activity of three protracted regimens for the control of cisplatin-evoked delayed emesis was explored. 63 patients were randomly assigned to receive one of three protracted antiemetic schedules over 4 days. Group C patients received dexamethasone 8 mg twice daily on days 2 and 3, then 4 mg twice daily on days 4 and 5; in group B, alizapride 2.5 mg/kg four times daily on days 2-5 plus dexamethasone as in group C was administered; and in group A, metoclopramide 0.5 mg/kg four times daily on days 2-5 plus dexamethasone was given at the same dose-schedule as in groups C and B. Complete protection from delayed vomiting was achieved in 44% of group C, 30% of B and 70% of group A (P = 0.02). Mild side-effects were noted in all three groups. A higher complete protection for delayed emesis was obtained in metoclopramide-dexamethasone-treated patients. Neither of the regimens used in the protection of delayed emesis controlled late nausea.lld:pubmed
pubmed-article:1515247pubmed:languageenglld:pubmed
pubmed-article:1515247pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1515247pubmed:citationSubsetIMlld:pubmed
pubmed-article:1515247pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1515247pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1515247pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1515247pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1515247pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1515247pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1515247pubmed:statusMEDLINElld:pubmed
pubmed-article:1515247pubmed:issn0959-8049lld:pubmed
pubmed-article:1515247pubmed:authorpubmed-author:CarlesJJlld:pubmed
pubmed-article:1515247pubmed:authorpubmed-author:RosellRRlld:pubmed
pubmed-article:1515247pubmed:authorpubmed-author:FongLLlld:pubmed
pubmed-article:1515247pubmed:authorpubmed-author:MorenoIIlld:pubmed
pubmed-article:1515247pubmed:authorpubmed-author:AbadAAlld:pubmed
pubmed-article:1515247pubmed:authorpubmed-author:BarnadasAAlld:pubmed
pubmed-article:1515247pubmed:authorpubmed-author:RibellesNNlld:pubmed
pubmed-article:1515247pubmed:authorpubmed-author:SolansRRlld:pubmed
pubmed-article:1515247pubmed:issnTypePrintlld:pubmed
pubmed-article:1515247pubmed:volume28Alld:pubmed
pubmed-article:1515247pubmed:ownerNLMlld:pubmed
pubmed-article:1515247pubmed:authorsCompleteYlld:pubmed
pubmed-article:1515247pubmed:pagination1344-7lld:pubmed
pubmed-article:1515247pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1515247pubmed:meshHeadingpubmed-meshheading:1515247-...lld:pubmed
pubmed-article:1515247pubmed:meshHeadingpubmed-meshheading:1515247-...lld:pubmed
pubmed-article:1515247pubmed:meshHeadingpubmed-meshheading:1515247-...lld:pubmed
pubmed-article:1515247pubmed:meshHeadingpubmed-meshheading:1515247-...lld:pubmed
pubmed-article:1515247pubmed:meshHeadingpubmed-meshheading:1515247-...lld:pubmed
pubmed-article:1515247pubmed:meshHeadingpubmed-meshheading:1515247-...lld:pubmed
pubmed-article:1515247pubmed:meshHeadingpubmed-meshheading:1515247-...lld:pubmed
pubmed-article:1515247pubmed:meshHeadingpubmed-meshheading:1515247-...lld:pubmed
pubmed-article:1515247pubmed:meshHeadingpubmed-meshheading:1515247-...lld:pubmed
pubmed-article:1515247pubmed:meshHeadingpubmed-meshheading:1515247-...lld:pubmed
pubmed-article:1515247pubmed:meshHeadingpubmed-meshheading:1515247-...lld:pubmed
pubmed-article:1515247pubmed:meshHeadingpubmed-meshheading:1515247-...lld:pubmed
pubmed-article:1515247pubmed:meshHeadingpubmed-meshheading:1515247-...lld:pubmed
pubmed-article:1515247pubmed:meshHeadingpubmed-meshheading:1515247-...lld:pubmed
pubmed-article:1515247pubmed:meshHeadingpubmed-meshheading:1515247-...lld:pubmed
pubmed-article:1515247pubmed:meshHeadingpubmed-meshheading:1515247-...lld:pubmed
pubmed-article:1515247pubmed:year1992lld:pubmed
pubmed-article:1515247pubmed:articleTitleComparison of three protracted antiemetic regimens for the control of delayed emesis in cisplatin-treated patients.lld:pubmed
pubmed-article:1515247pubmed:affiliationMedical Oncology Unit, Hospital Terrasa, Barcelona, Spain.lld:pubmed
pubmed-article:1515247pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1515247pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:1515247pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:1515247pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1515247lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1515247lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1515247lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1515247lld:pubmed